Dear Colleagues,

It is with great pleasure that we invite you to attend The 3rd International Virtual Congress on Controversies in Fibromyalgia (Fibromyalgia2021) which will take place 24-25 June 2021.

 

Even as our understanding regarding the pathogenesis and neuroscience underlying fibromyalgia and chronic pain rapidly expand and proliferate in recent years, heated controversies remain regarding many aspects of fibromyalgia, regarding its place in medicine and society and regarding the best ways to alleviate suffering.

 

                              Dr. Jacob Ablin
          Tel-Aviv Sourasky Medical Center, Israel
                              Congress Co-Chair

 

                        Prof. Piercarlo Sarzi-Puttini
                L. Sacco University Hospital, Milan, Italy
                                    Congress Co-Chair

 

 

READ MORE

VIRTUAL CONGRESS

Unique Learning Experience for Medical Professionals
Click Here

REGISTER NOW

Regular Registration Deadline:
31 May 2021
Click Here

SPONSORSHIP PROSPECTUS

View Sponsorship
Opportunities
Click Here

EXHIBITION OPPORTUNITY

Join us as an Exhibitor
Special Price of €750
Click Here

Meet the Speakers

Daniel Clauw

University of Michigan, USA

Daniel Clauw, M.D is a Professor of Anesthesiology, Medicine and Psychiatry at the University of Michigan. He attended undergrad and… READ MORE
Mary-Ann Fitzcharles

McGill University, Canada

Mary-Ann Fitzcharles has worked as a clinician, teacher and clinical researcher at McGill University, Montreal Canada since 1982. She completed… READ MORE
Bart Morlion

Leuven Centre for Algology & Pain Management, University Hospitals of Leuven, Belgium

Bart Morlion trained as an anaesthesiologist but works since many years full time in pain medicine. He is the director… READ MORE
Serge Perrot

Cochin University Hospital, France

Serge Perrot is Rheumatologist and Pain Specialist He is currently Professor of Clinical Pharmacology at Paris University, and head of… READ MORE
All Speakers

Congress Program

09:30 CEST
Congress Opening & Welcome
Jacob Ablin, Israel & Piercarlo Sarzi-Puttini, Italy | Congress Chairs
09:40-10:00
Fibromyalgia: Year in review
Valeria Giorgi

L. Sacco University Hospital, Italy

10:00-10:20
Chronic Pain: Year in review
Valerie Aloush

Tel Aviv Sourasky Medical Center, Israel

10:20-10:40
Pain as a Symptom vs. Pain as a Syndrome
Eva Kosek

Karolinska Institute, Sweden

10:40-11:00
Time to Stop the Fibromyalgia Criteria Wars
Jacob Ablin

Tel-Aviv Sourasky Medical Center, Israel

11:00-11:20
Why do Drugs Work so Poorly in Fibromyalgia Patients?
Daniel Clauw

University of Michigan, USA

11:20-11:40
Fibromyalgia as a Disease of Misconnection
Serge Perrot

Cochin University Hospital, France

13:10-13:30
Chronic Fatigue Syndrome
Piercarlo Sarzi-Puttini

L. Sacco University Hospital, Italy

13:30-13:50
Functional Gastrointestinal Disorders
Maura Corsetti

Gastroenterology Unit, Nottingham Biomedical and Research Center, University of Nottingham, UK

13:50-14:10
Small-Fibre Neuropathy and Neuropathic Pain: Differential Diagnosis and Therapeutic Approach
Andrea Truini

Sapienza University, Rome, Italy

14:10-14:30
How Stress Becomes Neuropathic Pain
Manuel Martinez-Lavin

National Institute of Cardiology, Mexico

14:30-14:50
Classical Examples of the Concept of the ASIA Syndrome; CPI, SBI and vaccines
Yehuda Shoenfeld

Sheba Medical Center, Israel

14:50-15:10
Central Sensitization: Neurophysiological Mechanisms
Emanuel van den Broeke

Institute of Neuroscience, Faculty of Medicine, UC Louvain, Belgium

15:10-15:30
Mechanisms of Pain in Rheumatoid Arthritis
Ernest Choy

Section of Rheumatology, School of Medicine, Cardiff University, Cardiff, UK

15:30-15:50
Pain Chronification: What should a non-pain medicine specialist know?
Bart Morlion

Leuven Centre for Algology & Pain Management, University Hospitals of Leuven, Belgium

15:50-16:10
Biologic and Small Molecules: Do they work on pain?
Peter Taylor

Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, UK

09:00 CEST
Congress Welcome - Day 2
Jacob Ablin, Israel & Piercarlo Sarzi-Puttini, Italy I Congress Chairs
09:10-09:30
Widespread pain, fatigue, depression and sicca symptoms are overlapping features in primary Sjögren’s syndrome and fibromyalgia: differences and similarities of clinical and pathogenetic aspects
Claudio Vitali

'Mater Domini' Humanitas Hospital, Italy

09:30-09:50
Salivary Biomarkers in Fibromyalgia
Laura Bazzichi

Rheumatology Unit, AOU Pisana, Pisa, Italy

09:50-10:10
Neuroimaging of fibromyalgia: where do we stand?
Diana Torta

Health Psychology Research group, Faculty of Psychology and Educational Sciences, KU Leuven, Belgium

10:10-10:30
Why opioids should not be used to treat Fibromyalgia
Mary-Ann Fitzcharles

McGill University, Canada

10:30-10:50
Why and to what extent do Cannabinoids work in Fibromyalgia Patients?
Silviu Brill

Tel Aviv Medical Center, Israel

10:50-11:10
Effect of Different Drugs: Does it make sense in Fibromyalgia?
Winfried Häuser

Klinikum Saarbrücken, Germany

11:10-11:30
Multicomponent Treatment Strategies in Fibromyalgia
Jacob Ablin

Tel-Aviv Sourasky Medical Center, Israel

11:30-11:50
Therapeutic validity of exercise interventions in the management of Fibromyalgia
Roberto Casale

Opusmedica, PC&R Patient, Care & Research Network, Italy

Giorgio Ferriero

Physical and Rehabilitation Medicine, Università dell'Insubria, Varese, Italy

11:50-12:10
Neurofeedback
Ayelet Or Borichev

Tel-Aviv Sourasky Medical Center, Israel

12:10-12:30
Mind and Body Therapies
Piercarlo Sarzi-Puttini

L. Sacco University Hospital, Italy

13:45-13:55
The Institutional Role of ENFA
Gunilla Goran

President ENFA, Sweden

13:55-14:05
The mission of the Scientific Committee of ENFA
Karin Maria Øien Forseth

ENFA Board Member, Norway

14:05-14:15
The Role of Patients Association: Italy
Giuseppina Fabio

AISF ODV, Italy

14:15-14:25
The Role of Patients Association: Israel
Sharon Gur

ASAF, Israel

14:25-14:45
The role of registries in the analysis of FM data
Marco Di Carlo

Polytechnic University of Marche, Italy

14:45-15:05
What is relevant to assess clinical improvement?
Jose A. Pereira Da Silva

Department of Rheumatology, University of Coimbra, Portugal

15:05-15:25
Can patients achieve a persistent remission?
Eduardo S. Paiva

Universidade Federal do Parana, Brazil

Contact Us

Please drop us a line with any questions or comments you may have.

We look forward to hearing from you.